Scientist II, Degrader Antibody Conjugate Characterization
Nurix Therapeutics · Brisbane, California, United States
About the role
Nurix Therapeutics is hiring a Scientist II to develop analytical characterization workflows for its degrader-antibody conjugate (DAC) platform, including drug-to-antibody ratio (DAR) analysis, aggregation assessment, and quality-control protocols. The role centers on LC-MS and HPLC method development, high-throughput screening support, and building plate-based sample-prep workflows that inform go/no-go decisions on which conjugates advance. Requires 4+ years of relevant industry experience (depending on degree level) with ADC/DAC characterization, antibody analysis, and chromatographic methods, plus strong cross-functional collaboration with chemistry, biology, and bioanalytical teams.
Get new listings like this, weekly